Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Homecare Medicine Services
This framework agreement is for the provision of Homecare Medicines Services to member organisations in the East of England NHS Collaborative Procurement Hub (EOECPH), NHS Commercial Solutions (NHSCS), NHS London Procurement Partnership (NHS LPP), NHS North of England Commercial Procurement Collaborative (NOE CPC) and South East Pharmacy Procurement Service (SEPPS). Whilst focused for the benefit of these organisations, the framework agreement is intended to be available to any publicly funded entities subject to completion of the framework access agreement.
The Framework Agreement will be delivered through eight lots which are as follows:
Lot 1 - Low Tech Homecare Medicines Service
Lot 2 - Mid Tech Homecare Medicines Service
Lot 3 - Homecare Medicines Services for Antibiotic Products
Lot 4 - High Tech Homecare Medicines Service
Lot 5 - Homecare Medicines for Injectable Chemotherapy
Lot 6 - Hub and Spoke Controlled Pick-up Model
Lot 7 - Homecare Medicines Services for Immunoglobulin Therapies
Lot 8 – Homecare Medicines Services for Bleeding Disorders
Framework Length: 4 years (no extension options)
The questionnaire will run on:
The Atamis portal:
https://health-family.force.com/s/Welcome
How to access the Questionnaire on the portal:
Please respond to the questionnaire by no later than 12:00 Midday on Thursday 8 January 2026. Please note that the commissioners/contracting authority/customer / Trusts must not be contacted under any circumstances with regard to this project. All queries must be put through the clarification question process.
No supplier information available.
This procurement was divided into 8 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Low Tech Homecare Medicines Service May 2026 – Apr 2030 | £22,966,125,000 | active |
| Lot 2 Mid Tech Homecare Medicines Service May 2026 – Apr 2030 | £5,741,531,250 | active |
| Lot 3 Homecare Medicines Services for Antibiotic Products May 2026 – Apr 2030 | £1,913,843,750 | active |
| Lot 4 High Tech Homecare Medicines Service May 2026 – Apr 2030 | £1,913,843,750 | active |
| Lot 5 Homecare Medicines for Injectable Chemotherapy May 2026 – Apr 2030 | £1,913,843,750 | active |
| Lot 6 Hub and Spoke Controlled Pick-up Model May 2026 – Apr 2030 | £382,768,750 | active |
| Lot 7 Homecare Medicines Services for Immunoglobulin Therapies May 2026 – Apr 2030 | £1,913,843,750 | active |
| Lot 8 Homecare Medicines Services for Bleeding Disorders May 2026 – Apr 2030 | £1,531,075,000 | active |
Weightings from the notice, applied to every lot.